Clinical Trial Update: Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

This report presents the efficacy and safety outcomes from a Phase 3 trial of adalimumab in adults with moderate-to-severe chronic plaque psoriasis. The study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Psoriasis | Phase 3 | Status: COMPLETED